Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting
Proteomics can aid in the identification of molecular subtypes in cancers. Here, the authors perform proteomic profiling of 124 paired oesophageal cancer and adjacent non-tumour tissues and identify two subtypes that are associated with patient survival for therapeutic targeting.
Guardado en:
Autores principales: | Wei Liu, Lei Xie, Yao-Hui He, Zhi-Yong Wu, Lu-Xin Liu, Xue-Feng Bai, Dan-Xia Deng, Xiu-E Xu, Lian-Di Liao, Wan Lin, Jing-Hua Heng, Xin Xu, Liu Peng, Qing-Feng Huang, Cheng-Yu Li, Zhi-Da Zhang, Wei Wang, Guo-Rui Zhang, Xiang Gao, Shao-Hong Wang, Chun-Quan Li, Li-Yan Xu, Wen Liu, En-Min Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d695a233ef54642ace9e04ed24b5883 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes
por: Si-Yang Liu, et al.
Publicado: (2021) -
Molecular representation of coal-derived asphaltene based on high resolution mass spectrometry
por: Yonghong Zhu, et al.
Publicado: (2022) -
Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer
por: Xue Li, et al.
Publicado: (2021) -
Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma
por: Yotsawat Pomyen, et al.
Publicado: (2021) -
Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics
por: Hai-yi Wang, et al.
Publicado: (2017)